Caitlin Cronin
Stock Analyst at Canaccord Genuity
(0)
# 2712
Out of 5,298 analysts
24
Total ratings
28.57%
Success rate
2.87%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TELA TELA Bio | Maintains: Buy | 12 7 | 1.08 | 548.15% | 4 | Mar 21, 2025 | |
SNN Smith & Nephew | Maintains: Hold | 27 27 | 26.31 | 2.62% | 1 | Mar 17, 2025 | |
BVS Bioventus | Maintains: Buy | 15 15 | 8.33 | 80.07% | 1 | Mar 17, 2025 | |
AXGN Axogen | Maintains: Strong Buy | 22 26 | 16.25 | 60% | 4 | Feb 26, 2025 | |
VCEL Vericel | Maintains: Strong Buy | 64 67 | 41.91 | 59.87% | 3 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 4 | 2.28 | 75.44% | 2 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 20 | 10.22 | 95.69% | 3 | Aug 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 21 16 | 15.71 | 1.85% | 2 | Jul 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | 130 | 107.45 | 20.99% | 1 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 73 75 | 32.52 | 130.63% | 1 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 79 | 69.01 | 14.48% | 1 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 270 12 | 5.47 | 119.38% | 1 | Nov 14, 2023 |